Home > Insider Trading > Filing (0001209191-21-024229)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1807120	Design Therapeutics Inc.	DSGN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1580787	Pratik Shah	C/O Design Therapeutics, Inc. 6005 Hidden Valley Road, Suite 110 Carlsbad CA 92011	Executive Chairperson	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-03-30	25,000	$20.00	25,000	No	4	P	Direct
Common Stock	Acquisiton	2021-03-30	104,923	$0.00	129,923	No	4	C	Indirect	By Pratik Shah Living Trust (6/15/2011)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Indirect	By Pratik Shah Living Trust (6/15/2011)

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2021-03-30	171,025	$0.00	104,923	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

The shares were purchased in the Issuer's initial public offering.
All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
The Reporting Person is the Trustee of the Pratik Shah Living Trust (6/15/2011). The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.